Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator–controlled phase 3 AMAGINE-2 trial
收藏Mendeley Data2026-04-18 收录
官方服务：
资源简介：
Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator–controlled phase 3 AMAGINE-2 trial
布罗利单抗（brodalumab）治疗银屑病的长期疗效与安全性：随机双盲、安慰剂与活性对照3期AMAGINE-2临床试验120周结果
创建时间：
2019-06-03
